Oral doxifluridine in advanced hepatocellular carcinoma: A phase II study.
Lencioni M, Falcone A, Allegrini G, Pfanner E, Masi G, Brunetti I, Di Marsico R, Fontana E, Orlandini C, Stampino CG, Bartolozzi C, Conte PF.
Lencioni M, et al. Among authors: orlandini c.
Oncology. 2000 Sep;59(3):204-9. doi: 10.1159/000012162.
Oncology. 2000.
PMID: 11053987
Clinical Trial.